Emerging strategies for ESKAPE treatment

Detalhes bibliográficos
Autor(a) principal: Rosa, Taciéli Fagundes da
Data de Publicação: 2020
Outros Autores: Foletto, Vitória Segabinazzi, Serafin, Marissa Bolson, Bottega, Angelita, Hörner, Rosmari
Tipo de documento: Artigo
Idioma: por
Título da fonte: Saúde (Santa Maria)
Texto Completo: https://periodicos.ufsm.br/revistasaude/article/view/43061
Resumo: The persistent use of antibiotics, self-medication and exposure to hospital infections has led to an increase in multidrug-resistant microorganisms. With this emergence of bacterial multiresistance, six pathogens play an essential role. The term ESKAPE deals with six microorganisms with high multiresistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. The World Health Organization (WHO) recently released a list of priority pathogens for research and development of new antibacterial agents. All ESKAPE pathogens are on this list. Thus, listing a big question: the emerging importance of new treatment strategies for infections caused by these microorganisms.
id UFSM-14_30cf22c632f10c194d631fbbcd28d7db
oai_identifier_str oai:ojs.pkp.sfu.ca:article/43061
network_acronym_str UFSM-14
network_name_str Saúde (Santa Maria)
repository_id_str
spelling Emerging strategies for ESKAPE treatmentEstratégias emergentes para tratamento de ESKAPEBacteriaMicrobiologyTherapy.BactériasMicrobiologiaTerapêutica.The persistent use of antibiotics, self-medication and exposure to hospital infections has led to an increase in multidrug-resistant microorganisms. With this emergence of bacterial multiresistance, six pathogens play an essential role. The term ESKAPE deals with six microorganisms with high multiresistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. The World Health Organization (WHO) recently released a list of priority pathogens for research and development of new antibacterial agents. All ESKAPE pathogens are on this list. Thus, listing a big question: the emerging importance of new treatment strategies for infections caused by these microorganisms.O persistente uso de antibióticos, automedicação e exposição a infecções hospitalares têm provocado o aumento de microrganismos multirresistentes. Com essa emergência da multirresistência bacteriana, seis patógenos figuram papel essencial. O termo ESKAPE trata de seis microrganismos com alta multirresistência e virulência: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa e Enterobacter spp. Recentemente, a Organização Mundial da Saúde (OMS) liberou uma lista de agentes patogênicos prioritários para pesquisa e desenvolvimento de novos agentes antibacterianos. Todos os patógenos ESKAPE fazem parte desta lista. Elencando, assim, uma grande questão: a importância emergente de novas estratégias de tratamento para infecções ocasionadas por esses microrganismos.Universidade Federal de Santa Maria2020-04-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufsm.br/revistasaude/article/view/4306110.5902/2236583443061Saúde (Santa Maria); Revista Saúde (Santa Maria), Vol.46, n.1, jan.-abr. 2020Saúde (Santa Maria); Revista Saúde (Santa Maria), Vol.46, n.1, jan.-abr. 20202236-58340103-4499reponame:Saúde (Santa Maria)instname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMporhttps://periodicos.ufsm.br/revistasaude/article/view/43061/pdf_1Copyright (c) 2020 Saúde (Santa Maria)info:eu-repo/semantics/openAccessRosa, Taciéli Fagundes daFoletto, Vitória SegabinazziSerafin, Marissa BolsonBottega, AngelitaHörner, Rosmari2020-04-28T17:42:23Zoai:ojs.pkp.sfu.ca:article/43061Revistahttps://periodicos.ufsm.br/revistasaudePUBhttps://periodicos.ufsm.br/revistasaude/oairevistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com2236-58342236-5834opendoar:2020-04-28T17:42:23Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Emerging strategies for ESKAPE treatment
Estratégias emergentes para tratamento de ESKAPE
title Emerging strategies for ESKAPE treatment
spellingShingle Emerging strategies for ESKAPE treatment
Rosa, Taciéli Fagundes da
Bacteria
Microbiology
Therapy.
Bactérias
Microbiologia
Terapêutica.
title_short Emerging strategies for ESKAPE treatment
title_full Emerging strategies for ESKAPE treatment
title_fullStr Emerging strategies for ESKAPE treatment
title_full_unstemmed Emerging strategies for ESKAPE treatment
title_sort Emerging strategies for ESKAPE treatment
author Rosa, Taciéli Fagundes da
author_facet Rosa, Taciéli Fagundes da
Foletto, Vitória Segabinazzi
Serafin, Marissa Bolson
Bottega, Angelita
Hörner, Rosmari
author_role author
author2 Foletto, Vitória Segabinazzi
Serafin, Marissa Bolson
Bottega, Angelita
Hörner, Rosmari
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Rosa, Taciéli Fagundes da
Foletto, Vitória Segabinazzi
Serafin, Marissa Bolson
Bottega, Angelita
Hörner, Rosmari
dc.subject.por.fl_str_mv Bacteria
Microbiology
Therapy.
Bactérias
Microbiologia
Terapêutica.
topic Bacteria
Microbiology
Therapy.
Bactérias
Microbiologia
Terapêutica.
description The persistent use of antibiotics, self-medication and exposure to hospital infections has led to an increase in multidrug-resistant microorganisms. With this emergence of bacterial multiresistance, six pathogens play an essential role. The term ESKAPE deals with six microorganisms with high multiresistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. The World Health Organization (WHO) recently released a list of priority pathogens for research and development of new antibacterial agents. All ESKAPE pathogens are on this list. Thus, listing a big question: the emerging importance of new treatment strategies for infections caused by these microorganisms.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-21
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.ufsm.br/revistasaude/article/view/43061
10.5902/2236583443061
url https://periodicos.ufsm.br/revistasaude/article/view/43061
identifier_str_mv 10.5902/2236583443061
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.ufsm.br/revistasaude/article/view/43061/pdf_1
dc.rights.driver.fl_str_mv Copyright (c) 2020 Saúde (Santa Maria)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Saúde (Santa Maria)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.source.none.fl_str_mv Saúde (Santa Maria); Revista Saúde (Santa Maria), Vol.46, n.1, jan.-abr. 2020
Saúde (Santa Maria); Revista Saúde (Santa Maria), Vol.46, n.1, jan.-abr. 2020
2236-5834
0103-4499
reponame:Saúde (Santa Maria)
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Saúde (Santa Maria)
collection Saúde (Santa Maria)
repository.name.fl_str_mv Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv revistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com
_version_ 1799944001798799360

Registros relacionados